Maternal Plasma miRNAs as Early Biomarkers of Moderate-to-Late-Preterm Birth

• Published in: International journal of molecular sciences Vol. 25; no. 17; p. 9536
• Main Authors: Ramzan, Farha, Rong, Jing, Roberts, Claire T, O'Sullivan, Justin M, Perry, Jo K, Taylor, Rennae, McCowan, Lesley, Vickers, Mark H
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 02.09.2024
• Subjects: Adult; biomarker; Biomarkers; Biomarkers - blood; Cell cycle; epigenetics; Female; Genes; Gestational Age; Humans; Iatrogenesis; Infant, Newborn; MicroRNAs; MicroRNAs - blood; MicroRNAs - genetics; miRNA; Plasma; Preeclampsia; Pregnancy; Pregnancy complications; Premature birth; Premature Birth - blood; Premature Birth - genetics; preterm birth; preterm birth; miRNA; biomarker; epigenetics; pregnancy
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25179536

Globally, preterm birth (PTB) is a primary cause of mortality and morbidity in infants, with PTB rates increasing worldwide over the last two decades. Biomarkers for accurate early prediction of PTB before the clinical event do not currently exist. Given their roles in the development and progression of many disease states, there has been increasing interest in the utility of microRNAs (miRNAs) as early biomarkers for pregnancy-related disorders, including PTB. The present study was designed to examine potential differences in miRNA abundances in maternal plasma from mothers with infants born following a moderate to late (28-36 weeks' gestation, n = 54) spontaneous PTB (SPTB) compared to mothers with matched term infants (n = 54). Maternal plasma collected at 15 weeks' gestation were utilised from the Auckland and Adelaide cohorts from the Screening for Pregnancy Endpoints (SCOPE) study. miRNAs in plasma were quantified using the NanoString nCounter expression panel (800 miRNAs). The top four most abundant miRNAs were significantly decreased in the plasma of mothers in the SPTB group with results consistent across both cohorts and pathway analysis was undertaken to examine the biological processes linked to the dysregulated miRNAs. The top candidate miRNAs (miRs-451a, -223-3p, let-7a-5p, and -126-3p) were linked to gene pathways associated with inflammation, apoptosis, and mitochondrial biogenesis. Moreover, miRNAs were consistently less abundant in the plasma of mothers of preterm infants across both sites, suggesting potential global dysregulation in miRNA biogenesis. This was supported by a significant downregulation in expression of key genes that are involved in miRNA biogenesis ( , , and ) across both sites in the SPTB group. In summary, the present study has identified miRNAs in maternal plasma that may provide predictive utility as early biomarkers for the risk of later SPTB. Importantly, these observations were conserved across two independent cohorts. Further, our data provide evidence for a persistent decrease in miRNA abundance in mothers who later experienced an SPTB, which is likely to have widespread consequences for gene regulation and epigenetic processes.